Paving the way to a new tumor regression grade in digestive oncology
-
Published:2024-07
Issue:
Volume:
Page:
-
ISSN:1590-8658
-
Container-title:Digestive and Liver Disease
-
language:en
-
Short-container-title:Digestive and Liver Disease
Author:
Bibeau F.,Molimard C.
Reference12 articles.
1. Bo Gao, Zehua Zhao, Xiaozhuo Gao, Tao Zhang, Ning Zhang, Yong Zhang et al. Role of pathological tumor regression grade of lymph node metastasis following neoadjuvant chemotherapy in locally advanced gastric cancer. Digestive and Liver Disease. In press. 2024.
2. Set for Reporting Carcinoma of the Stomach in Gastrectomy;Shi;Arch Pathol Lab Med,2022
3. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
4. Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial;Verschoor;Nat Med,2024
5. Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma;Wouters;Ann Oncol,2021